This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Agios Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Eric Simone: Innovator in Pharmaceutical Chemistry
Introduction
Eric Simone is a notable inventor based in West Newbury, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work focuses on addressing conditions associated with pyruvate kinase, which is crucial for various metabolic processes.
Latest Patents
Eric Simone holds 1 patent for his invention titled "Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide." This patent provides details on amorphous and crystalline hemisulfate salt forms of the compound. Additionally, it includes pharmaceutical compositions that utilize these forms, along with methods for their manufacture and applications in treating pyruvate kinase deficiency.
Career Highlights
Throughout his career, Eric has been associated with Agios Pharmaceuticals, Inc., a company known for its focus on developing innovative therapies for cancer and rare genetic diseases. His expertise in pharmaceutical chemistry has played a vital role in advancing the company's research and development efforts.
Collaborations
Eric has collaborated with various professionals in the field, including his coworker, Jose Luis Rios Lizarraga. These collaborations have contributed to the successful development of new pharmaceutical solutions.
Conclusion
Eric Simone's work exemplifies the impact of innovation in pharmaceutical chemistry. His contributions continue to pave the way for advancements in treating metabolic disorders.